profit from every $100 of sales.
$0$100
Talkspace
We have no price for Talkspace since 18 August 2026. It may have been taken over, merged or renamed, so the figures below are from then.
$5.25+0.00% today
+73.8% since Oct 10, 25
1-year low $2.631-year high $5.25
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay $111.71 for every $1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Talkspace sold, what it kept, and what it did with the cash.
Sales went from $120 million in 2022 to $229 million in 2025, with $7.79 million of profit last year.
SalesProfit
Talkspace vs. similar companies
Talkspace grows the fastest of these 5 and is the most expensive for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Talkspace | 111.7× · Very expensive | ||
 Tenet Healthcare | 16.2× · Fair price | ||
 Solventum | 9.7× · Cheap | ||
 Encompass Health | 24.4× · Fair price | ||
 Fresenius Medical Care AG & Co. KGaA | 10.6× · Cheap |
AI analysis
An AI analyst reads Talkspace's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 120 | 150 | 188 | 229 | |
| 60 | 75 | 86 | 98 | |
| -77 | -23 | -4 | 3 | |
| -76 | -22 | -4 | 6 | |
| -80 | -19 | 1 | 8 | |
| -0.51 | -0.12 | 0.01 | 0.04 | |
| 50.5% | 49.9% | 46.0% | 43.0% | |
| -64.4% | -15.5% | -2.4% | 1.4% | |
| -66.6% | -12.8% | 0.6% | 3.4% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 156 | 142 | 139 | 135 |
| Cash | 139 | 124 | 77 | 37 |
| Total debt | – | – | – | – |
| Total liabilities | 29 | 24 | 21 | 18 |
| 128 | 119 | 117 | 117 | |
| 157 | 165 | 176 | 174 | |
| -47.7% | -15.5% | -3.0% | 2.1% | |
| -62.5% | -16.2% | 1.0% | 6.7% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -61 | -16 | 11 | 9 | |
| 0 | 0 | 5 | 11 | |
| -61 | -16 | 6 | -2 | |
| Dividends paid | – | – | – | – |
| 0 | 0 | 11 | 17 | |
| 12 | 8 | 9 | 8 |
Valuation
- 111.7×
- 38.7×
- –
- 7.7×
- 3.8×
- –
- 138.2×
- -0.2%
- 0.9%
- 0.0%
Profitability
- 43.0%
- 1.4%
- 3.4%
- 2.6%
- -1.7%
- -20.7%
- 1.0%
- 0.9%
- -2.5%
- 4.9%
Growth
- +24.2%
- –
- −133.7%
- –
- +2.3%
Financial health
- -5.1×
- 0.00
- 0.0%
- -3.1×
- 4.84
- 4.84
- 1.75
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 31%of 952
Bottom 28%of 883
Bottom 7%of 601
Top 23%of 888
Bottom 37%of 987
What analysts expect
- Average price target
- $5.25
- Range
- $5.25 – $5.25
- 2 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 11, 2026 | -0.04 | 0.02 | −300.0% |
| Feb 19, 2026 | 0.03 | 0.02 | +50.0% |
| Oct 30, 2025 | 0.02 | 0.02 | +0.0% |
| Aug 5, 2025 | -0.00 | 0.01 | −132.2% |
| May 6, 2025 | 0.00 | – | – |
| Feb 20, 2025 | 0.01 | 0.01 | +0.0% |
| Oct 29, 2024 | 0.01 | 0.00 | +233.3% |
| Aug 6, 2024 | -0.00 | -0.00 | −100.0% |
News
'They Don't Want to Talk About It': Top Analyst Says Apple Has a Siri Problem in an Era of Personalized AgentsYahoo Finance · Nov 3, 2026Stock Market Today: Dow Up, These Stocks Gain On Musk Talk; DoorDash Dives (Live Coverage)Yahoo Finance · Oct 26, 2026Frank Talk: Gold miners beat every S&P 500 sector in Q3 despite September selloffYahoo Finance · Oct 9, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
33No pass
Benjamin Graham
30No pass
Philip Fisher
34No pass
Peter Lynch
80Pass
Joel Greenblatt
2No pass
Charlie Munger
24No pass
Terry Smith
23No pass
Questions about Talkspace
Is Talkspace a good stock to buy?
A business with weak numbers, priced as if everything goes right. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Talkspace AI analysis
What does Talkspace do?
Talkspace, Inc. operates as a virtual behavior healthcare company. It delivers healthcare through encrypted web and mobile platform. The company offers treatment options for every need, including psychiatry or adolescent, individual, or couples therapy. It is in Medical - Care Facilities.
Does Talkspace pay a dividend?
No. Talkspace does not pay a dividend at the moment; in 2025 it returned $17.2 million to shareholders by buying back its own shares.
Is Talkspace stock halal?
Yes. Talkspace passes our halal screen: its business is permitted and its debt is 0% of its market value, under the 30% limit. How we check
Who are Talkspace's competitors?
The largest listed companies in the same industry are Tenet Healthcare, Solventum, Encompass Health and Fresenius Medical Care AG & Co. KGaA. The peers table on this page compares their profit, growth and price with Talkspace's.
Prices: daily closes to Aug 18, 2026. Fundamentals: company reports via invest-like data.